✦ LIBER ✦

Modulation of the haematopoietic toxicity associated with zidovudine in vivo with lithium carbonate

✍ Scribed by V. S. GALLICCHIO; N. K. HUGHES; K. F. TSE

Book ID: 114742535
Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 561 KB
Volume: 233
Category: Article
ISSN: 0954-6820
DOI: 10.1111/j.1365-2796.1993.tb00985.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effective modulation of the haematopoiet

Effective modulation of the haematopoietic toxicity associated with zidovudine exposure to murine and human haematopoietic progenitor stem cells in vitro with lithium chloride

✍ Dr. V. S. GALLICCHIO; N. K. HUGHES 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

Lithium carbonate therapy for zidovudine

Lithium carbonate therapy for zidovudine-associated neutropenia in patients with acquired immunodeficiency syndrome

✍ Neil E. Klutman 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Effect of lithium carbonate on zidovudin

Effect of lithium carbonate on zidovudine-associated neutropenia in the acquired immunodeficiency syndrome

✍ Douglas E. Roberts; Stephen M. Berman; Sharlene Nakasato; Frederic A. Wyle; Rodn 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 555 KB

In-vivo effect of interleukin 3 and eryt

In-vivo effect of interleukin 3 and erythropoietin, either alone or in combination, on the hematopoietic toxicity associated with zidovudine

✍ Vincent S. Gallicchio; Nedda K. Hughes; Kam-Fai Tse 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 968 KB

SEVERE DIARRH&#x152;A ASSOCIATED WIT

SEVERE DIARRH&#x152;A ASSOCIATED WITH LITHIUM-CARBONATE THERAPY IN REGIONAL ILEITIS

✍ Wand, R.R.; Varsamis, J. 📂 Article 📅 1972 🏛 The Lancet 🌐 English ⚖ 167 KB

Intermittent selection pressure with zid

Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations

✍ Izopet, J.; Sailler, L.; Sandres, K.; Pasquier, C.; Bonnet, E.; Aquilina, C.; Pu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

The development of mutations conferring drug resistance was investigated in 49 antiretroviralnaive asymptomatic HIV-1 subjects with CD4 + cell counts of 250-500/mm 3 given intermittent (6-week courses, 6 weeks apart) or continuous treatment with zidovudine (AZT) plus zalcitabine (ddC) over 54 weeks.